Eletriptan Hydrobromide
Product manufactured by Zydus Pharmaceuticals (Usa) Inc.
Indications and Purposes
| 1 Indications And Usage Eletriptan Hydrobromide Tablets Are A Serotonin (5-Ht 1b/ 1d ) Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults ( 1 ) Limitations Of Use: Use Only After A Clear Diagnosis Of Migraine Has Been Established ( 1 ) Not Indicated For The Prophylactic Therapy Of Migraine ( 1 ) Not Indicated For The Treatment Of Cluster Headache ( 1 ). Eletriptan Hydrobromide Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Eletriptan Hydrobromide, Reconsider The Diagnosis Of Migraine Before Eletriptan Hydrobromideis Administered To Treat Any Subsequent Attacks. Eletriptan Hydrobromidetablets Arenot Intended For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Eletriptan Hydrobromidehave Not Been Established For Cluster Headache. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Eletriptan Hydrobromide |
|
ZINC3823475 |